Stefano Comai Selected Research

N- (2- ((3- bromophenyl)- (4- fluorophenyl)amino)ethyl)acetamide

1/2018	Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain.
10/2015	Antinociceptive properties of selective MT(2) melatonin receptor partial agonists.
2/2015	Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Comai Research Topics

Disease

5	Depressive Disorder (Melancholia) 01/2022 - 01/2015
5	Sleep Wake Disorders 10/2020 - 12/2011
5	Pain (Aches) 05/2019 - 01/2014
5	Neuralgia (Stump Neuralgia) 01/2019 - 02/2015
4	Bipolar Disorder (Manic Depressive Psychosis) 04/2022 - 12/2019
4	Inflammation (Inflammations) 04/2022 - 10/2020
4	Mood Disorders (Mood Disorder) 01/2019 - 01/2014
3	Infections 11/2021 - 03/2007
3	Psychotic Disorders (Schizoaffective Disorder) 10/2020 - 01/2014
3	Mental Disorders (Mental Disorder) 01/2019 - 01/2011
3	Substance-Related Disorders (Drug Abuse) 01/2019 - 10/2016
2	Alcoholism (Alcohol Abuse) 11/2021 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 05/2021 - 01/2014
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019 - 10/2016
2	Personality Disorders (Personality Disorder) 01/2019 - 01/2018
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2018 - 01/2014
1	Treatment-Resistant Depressive Disorder 01/2022
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 11/2021
1	Major Depressive Disorder (Major Depressive Disorders) 09/2021
1	Parkinsonian Disorders (Parkinsonism) 05/2021
1	Social Phobia 01/2021
1	Autism Spectrum Disorder 01/2021
1	Hyperalgesia 01/2019
1	Anxiety Disorders (Anxiety Disorder) 01/2019
1	Nervous System Diseases (Neurological Disorders) 01/2019
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019
1	Cognitive Dysfunction 01/2018
1	Antisocial Personality Disorder (Antisocial Personality) 10/2016
1	Epilepsy (Aura) 01/2016
1	Chronic Pain 10/2015

Drug/Important Bio-Agent (IBA)

11	Tryptophan (L-Tryptophan)FDA Link 04/2022 - 12/2004
8	MelatoninIBA 10/2020 - 03/2007
6	KynurenineIBA 04/2022 - 12/2019
6	Serotonin (5 Hydroxytryptamine)IBA 01/2019 - 08/2006
5	Neurotransmitter Agents (Neurotransmitter)IBA 05/2019 - 01/2014
5	MT2 Melatonin ReceptorIBA 01/2019 - 01/2014
4	Antidepressive Agents (Antidepressants)IBA 03/2022 - 01/2018
3	Pharmaceutical PreparationsIBA 04/2022 - 10/2015
3	Antipsychotic Agents (Antipsychotics)IBA 03/2022 - 11/2016
3	N- (2- ((3- bromophenyl)- (4- fluorophenyl)amino)ethyl)acetamideIBA 01/2018 - 02/2015
3	Analgesics (Analgesic Drugs)IBA 01/2018 - 02/2015
3	5-Hydroxytryptophan (5 Hydroxytryptophan)IBA 10/2016 - 03/2007
2	Valproic Acid (Depakote)FDA LinkGeneric 04/2022 - 01/2016
2	CytokinesIBA 01/2022 - 11/2021
2	Cocaine (Cocaine HCl)IBA 11/2021 - 01/2019
2	Proteins (Proteins, Gene)FDA Link 05/2021 - 01/2018
2	Dopamine (Intropin)FDA LinkGeneric 05/2021 - 01/2016
2	LigandsIBA 01/2019 - 02/2015
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2018 - 02/2015
2	Quetiapine Fumarate (Seroquel)FDA Link 01/2018 - 01/2014
2	Olanzapine (Zyprexa)FDA Link 01/2018 - 01/2014
2	N- (2- ((3- methoxyphenyl)phenylamino)ethyl)acetamideIBA 01/2018 - 10/2015
2	EnzymesIBA 01/2017 - 12/2004
2	Biological ProductsIBA 10/2016 - 01/2015
2	acetamideIBA 10/2015 - 02/2015
2	Hypnotics and Sedatives (Sedatives)IBA 01/2014 - 12/2011
1	LithiumIBA 04/2022
1	Lamotrigine (Lamictal)FDA LinkGeneric 04/2022
1	Biomarkers (Surrogate Marker)IBA 11/2021
1	Fatty Acid-Binding ProteinsIBA 11/2021
1	A-factor (Streptomyces)IBA 11/2021
1	Biological FactorsIBA 09/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2021
1	Hallucinogens (Psychedelics)IBA 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2020
1	Dizocilpine Maleate (Dizocilpine)IBA 10/2020
1	palmidrolIBA 01/2019
1	CopperIBA 01/2019
1	CannabidiolIBA 01/2019
1	CadmiumIBA 01/2019
1	Trace Elements (Biometals)IBA 01/2019
1	ZincIBA 01/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	MT1 Melatonin ReceptorIBA 01/2019
1	5-HT1A Serotonin ReceptorIBA 01/2019
1	BenzodiazepinesIBA 01/2018
1	suvorexantIBA 01/2018
1	Amitriptyline (Elavil)FDA LinkGeneric 01/2018
1	agomelatine (S20098)IBA 01/2018
1	ramelteon (Rozerem)FDA Link 01/2018
1	zaleplon (Sonata)FDA LinkGeneric 01/2018
1	Mirtazapine (Rexer)FDA LinkGeneric 01/2018
1	Zolpidem (Ambien)FDA LinkGeneric 01/2018
1	Pregabalin (Lyrica)FDA Link 01/2018
1	zopiclone (Zop)IBA 01/2018
1	Trazodone (Trittico)FDA LinkGeneric 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Doxepin (Mareen)FDA LinkGeneric 01/2018
1	Serotonin ReceptorsIBA 01/2017
1	Lysergic Acid Diethylamide (LSD)IBA 11/2016
1	gamma-Aminobutyric Acid (GABA)IBA 01/2016
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2016
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	Formaldehyde (Formol)FDA Link 10/2015

Therapy/Procedure

2	Precision Medicine 04/2022 - 11/2021
2	Therapeutics 01/2014 - 01/2011
1	Analgesia 01/2019
1	Drug Therapy (Chemotherapy) 01/2018